Oribiotech

Biotech company focused on advancing cell and gene therapy manufacturing through innovative automation tool

placeLondon, England, United Kingdom calendar_todayFounded 2015 groups11 employees language oribiotech.com

Registered entities

Social engagement

Social engagement: 19.5K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

19 investors on record; lead investors include Amadeus Capital, Delin Ventures, Kindred Capital, Novalis LifeSciences.

Investor typeCountShare
Venture capital737%
Private equity15%
Other / undisclosed1158%

Recent activity

2 Jul 2026
Partnership
ImmuXell Biotech
25 Jun 2026
Event
CAR-T Manufacturing Webinar with BlueWhale Bio on Cell-derived nanoparticle (CDNP)-based activation paired with IRO®
23 Jun 2026
Product launch
IRO®
Coming soon